FdaApplication
NDA 021957
Identifiers
- fda_app_no: NDA021957
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2006-10-20 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 2.5MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
| NEXIUM | ESOMEPRAZOLE MAGNESIUM | EQ 40MG BASE/PACKET | FOR SUSPENSION, DELAYED RELEASE;ORAL |
4 products